63 results on '"Moccia, Marcello"'
Search Results
2. Tango classes in people with Multiple Sclerosis (PwMS): Impact on motor and non-motor functions
3. Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis
4. Exploring the relation between reserve and fatigue in multiple sclerosis
5. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026
6. Epidemiology of multiple sclerosis in the Campania Region (Italy): Derivation and validation of an algorithm to calculate the 2015-2020 incidence
7. The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study
8. Multiple sclerosis progression: time for a new mechanism-driven framework
9. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
10. Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis
11. Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019
12. ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial
13. Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis
14. Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group
15. Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosis
16. Generalised boundary shift integral for longitudinal assessment of spinal cord atrophy
17. The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosis
18. Spinal cord atrophy in a primary progressive multiple sclerosis trial: Improved sample size using GBSI
19. Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis
20. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study
21. Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin
22. Notch3 protein expression in skin fibroblasts from CADASIL patients
23. A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing‐remitting multiple sclerosis
24. Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a
25. CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients
26. Molecular and Metabolic Imaging in Multiple Sclerosis
27. Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study
28. Switching to ozanimod as a strategy to adjust fingolimod-related lymphopenia
29. Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis
30. White matter changes and the development of motor phenotypes in de novo Parkinson's Disease
31. The Dress: Transforming a web viral event into a scientific survey
32. Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease
33. Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study
34. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients
35. Quitting smoking: An early non-motor feature of Parkinson's disease?
36. Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients
37. Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages
38. Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients
39. Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series
40. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients
41. Monitoring of safety and effectiveness of cladribine in multiple sclerosis patients over 50 years
42. Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis
43. Retinal and choriocapillary vascular changes in early stages of multiple sclerosis: A prospective study
44. Cardiovascular risk is associated with verbal learning dysfunction in multiple sclerosis
45. Ocrelizumab treatment in multiple sclerosis: Prospective real world observational multi-center study in Campania, Italy
46. Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: The hidden part of the iceberg
47. Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
48. COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak
49. Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features
50. Caffeine consumption and the 4-year progression of de novo Parkinson's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.